Deferred Tax Assets, Net of Valuation Allowance of MADRIGAL PHARMACEUTICALS, INC. from 31 Dec 2016 to 31 Dec 2025
- Taxonomy & unit
- us-gaap: USD
- Description
- Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
- Summary
-
MADRIGAL PHARMACEUTICALS, INC. quarterly Deferred Tax Assets, Net of Valuation Allowance in USD history and change rate from 31 Dec 2016 to 31 Dec 2025.
- MADRIGAL PHARMACEUTICALS, INC. Deferred Tax Assets, Net of Valuation Allowance for the quarter ending 31 Dec 2025 was $362,000, a 67% increase year-over-year.
- Source SEC data
- View on sec.gov
Deferred Tax Assets, Net of Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Net of Valuation Allowance, YoY Quarterly Change (%)
MADRIGAL PHARMACEUTICALS, INC. Quarterly Deferred Tax Assets, Net of Valuation Allowance (USD)
| Period | Value | YoY Chg | Change % | Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | $362,000 | +$145,000 | +67% | 31 Dec 2025 | 10-K | 19 Feb 2026 | 2025 | FY |
| Q4 2024 | $217,000 | +$100,000 | +85% | 31 Dec 2024 | 10-K | 19 Feb 2026 | 2025 | FY |
| Q4 2023 | $117,000 | +$117,000 | 31 Dec 2023 | 10-K | 19 Feb 2026 | 2025 | FY | |
| Q4 2022 | $0 | $0 | 31 Dec 2022 | 10-K | 26 Feb 2025 | 2024 | FY | |
| Q4 2021 | $0 | -$14,000 | -100% | 31 Dec 2021 | 10-K | 28 Feb 2024 | 2023 | FY |
| Q4 2020 | $14,000 | -$48,000 | -77% | 31 Dec 2020 | 10-K/A | 03 Mar 2023 | 2022 | FY |
| Q4 2019 | $62,000 | 31 Dec 2019 | 10-K | 24 Feb 2022 | 2021 | FY | ||
| Q4 2016 | $283,000 | 31 Dec 2016 | 10-K | 27 Feb 2019 | 2018 | FY |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.